BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 37634703)

  • 21. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Checklist for Artificial Intelligence in Medical Imaging Reporting Adherence in Peer-Reviewed and Preprint Manuscripts With the Highest Altmetric Attention Scores: A Meta-Research Study.
    Sivanesan U; Wu K; McInnes MDF; Dhindsa K; Salehi F; van der Pol CB
    Can Assoc Radiol J; 2023 May; 74(2):334-342. PubMed ID: 36301600
    [No Abstract]   [Full Text] [Related]  

  • 23. A systematic analysis of preprints in Trauma & Orthopaedic surgery.
    Hodel S; Selman F; Mania S; Maurer SM; Laux CJ; Farshad M
    Bone Jt Open; 2022 Aug; 3(8):582-588. PubMed ID: 35848996
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Social Media and Research Publication Activity During Early Stages of the COVID-19 Pandemic: Longitudinal Trend Analysis.
    Taneja SL; Passi M; Bhattacharya S; Schueler SA; Gurram S; Koh C
    J Med Internet Res; 2021 Jun; 23(6):e26956. PubMed ID: 33974550
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Releasing a preprint is associated with more attention and citations for the peer-reviewed article.
    Fu DY; Hughey JJ
    Elife; 2019 Dec; 8():. PubMed ID: 31808742
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The experiences of COVID-19 preprint authors: a survey of researchers about publishing and receiving feedback on their work during the pandemic.
    Rzayeva N; Henriques SO; Pinfield S; Waltman L
    PeerJ; 2023; 11():e15864. PubMed ID: 37637174
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Single-center trials show larger treatment effects than multicenter trials: evidence from a meta-epidemiologic study.
    Dechartres A; Boutron I; Trinquart L; Charles P; Ravaud P
    Ann Intern Med; 2011 Jul; 155(1):39-51. PubMed ID: 21727292
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Review of COVID-19-Related Publications and Lag Times During the First Six Months of the Year 2020.
    Carvalho CJ; Fuller MP; Quaidoo EA; Haider AS; Rodriguez JJ; Wong AHK; Duong MM; Rodriguez RM
    West J Emerg Med; 2021 Jun; 22(4):958-962. PubMed ID: 35354008
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Three out of four published systematic reviews on COVID-19 treatments were not registered and one-third of those registered were published: a meta-research study.
    Siemens W; Nothacker J; Stadelmaier J; Meerpohl JJ; Schmucker C
    J Clin Epidemiol; 2022 Dec; 152():36-46. PubMed ID: 36179937
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Counterpoint: Preprints and the Future of Scientific Publishing-In Favor of Relevance.
    Glymour MM; Charpignon ML; Chen YH; Kiang MV
    Am J Epidemiol; 2023 Jul; 192(7):1043-1046. PubMed ID: 36958814
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exploring the use of preprints in dentistry.
    Sarkis-Onofre R; Girotto C; Agostini BA
    J Dent; 2023 Sep; 136():104634. PubMed ID: 37488044
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparing quality of reporting between preprints and peer-reviewed articles in the biomedical literature.
    Carneiro CFD; Queiroz VGS; Moulin TC; Carvalho CAM; Haas CB; Rayêe D; Henshall DE; De-Souza EA; Amorim FE; Boos FZ; Guercio GD; Costa IR; Hajdu KL; van Egmond L; Modrák M; Tan PB; Abdill RJ; Burgess SJ; Guerra SFS; Bortoluzzi VT; Amaral OB
    Res Integr Peer Rev; 2020 Dec; 5(1):16. PubMed ID: 33292815
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interleukin-1 blocking agents for treating COVID-19.
    Davidson M; Menon S; Chaimani A; Evrenoglou T; Ghosn L; Graña C; Henschke N; Cogo E; Villanueva G; Ferrand G; Riveros C; Bonnet H; Kapp P; Moran C; Devane D; Meerpohl JJ; Rada G; Hróbjartsson A; Grasselli G; Tovey D; Ravaud P; Boutron I
    Cochrane Database Syst Rev; 2022 Jan; 1(1):CD015308. PubMed ID: 35080773
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of COVID-19 Preprint and Peer-Reviewed Versions of Studies on Therapies for Critically Ill Patients.
    Morin C; Padki A; Wong A; Miano T; Kane-Gill SL; Cozzi G; Deveau R
    J Intensive Care Med; 2023 Nov; 38(11):1060-1067. PubMed ID: 37337731
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Minimal reporting improvement after peer review in reports of COVID-19 prediction models: systematic review.
    Hudda MT; Archer L; van Smeden M; Moons KGM; Collins GS; Steyerberg EW; Wahlich C; Reitsma JB; Riley RD; Van Calster B; Wynants L
    J Clin Epidemiol; 2023 Feb; 154():75-84. PubMed ID: 36528232
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Postprints-to-preprints linkage to enhance access to scientific literature.
    Moustafa K
    Account Res; 2023 Dec; 30(7):542-546. PubMed ID: 34907810
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Examining linguistic shifts between preprints and publications.
    Nicholson DN; Rubinetti V; Hu D; Thielk M; Hunter LE; Greene CS
    PLoS Biol; 2022 Feb; 20(2):e3001470. PubMed ID: 35104289
    [TBL] [Abstract][Full Text] [Related]  

  • 38. COVID-19-Related manuscripts: lag from preprint to publication.
    Drzymalla E; Yu W; Khoury MJ; Gwinn M
    BMC Res Notes; 2022 Nov; 15(1):340. PubMed ID: 36335379
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmaceutical industry-authored preprints: scientific and social media impact.
    Subramanian K; Nalli A; Senthil V; Bhat A
    Curr Med Res Opin; 2021 Feb; 37(2):269-273. PubMed ID: 33206000
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reporting of funding and conflicts of interest improved from preprints to peer-reviewed publications of biomedical research.
    Itani D; Lababidi G; Itani R; El Ghoul T; Hamade L; Hijazi ARA; Khabsa J; Akl EA
    J Clin Epidemiol; 2022 Sep; 149():146-153. PubMed ID: 35738307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.